229 related articles for article (PubMed ID: 32918742)
21. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe
Hua YQ; Zeng Y; Xu J; Xu XL
Phytomedicine; 2021 Jan; 81():153412. PubMed ID: 33234364
[TBL] [Abstract][Full Text] [Related]
22. Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2.
Lee EH; Lee JH; Kim DY; Lee YS; Jo Y; Dao T; Kim KE; Song DK; Seo JH; Seo YK; Seong JK; Moon C; Han E; Kim MK; Ryu S; Shin M; Roh GS; Jung HR; Osborne TF; Ryu D; Jeon TI; Im SS
Exp Mol Med; 2024 Apr; 56(4):1001-1012. PubMed ID: 38622198
[TBL] [Abstract][Full Text] [Related]
23. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.
Jiang JX; Chen X; Fukada H; Serizawa N; Devaraj S; Török NJ
Hepatology; 2013 Oct; 58(4):1339-48. PubMed ID: 23703665
[TBL] [Abstract][Full Text] [Related]
24. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
[TBL] [Abstract][Full Text] [Related]
25. GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.
Zhang Y; Zhou X; Liu P; Chen X; Zhang J; Zhang H; Li S; Chen Y; Song X; Wang J; Zeng H; Zhang X; Tang C; Yu C; Li Y; Xu C
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G531-G542. PubMed ID: 33470903
[TBL] [Abstract][Full Text] [Related]
26. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy.
Stacchiotti A; Grossi I; García-Gómez R; Patel GA; Salvi A; Lavazza A; De Petro G; Monsalve M; Rezzani R
Cells; 2019 Sep; 8(9):. PubMed ID: 31500354
[TBL] [Abstract][Full Text] [Related]
27. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
28. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
29. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
31. MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.
He Y; Hwang S; Cai Y; Kim SJ; Xu M; Yang D; Guillot A; Feng D; Seo W; Hou X; Gao B
Hepatology; 2019 Oct; 70(4):1150-1167. PubMed ID: 30964207
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis.
Singuru G; Pulipaka S; Shaikh A; Balaji Andugulapati S; Thennati R; Kotamraju S
Int Immunopharmacol; 2023 Nov; 124(Pt B):111070. PubMed ID: 37862737
[TBL] [Abstract][Full Text] [Related]
33. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
35. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.
Allen J; Zhang J; Quickel MD; Kennett M; Patterson AD; Hankey-Giblin PA
J Proteome Res; 2018 Sep; 17(9):3268-3280. PubMed ID: 30091925
[TBL] [Abstract][Full Text] [Related]
36. Altered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.
Bruce KD; Szczepankiewicz D; Sihota KK; Ravindraanandan M; Thomas H; Lillycrop KA; Burdge GC; Hanson MA; Byrne CD; Cagampang FR
Biochim Biophys Acta; 2016 Jul; 1861(7):584-93. PubMed ID: 27040510
[TBL] [Abstract][Full Text] [Related]
37. Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis.
Lee H; Kim E; Shin EA; Shon JC; Sun H; Kim JE; Jung JW; Lee H; Pinanga Y; Song DG; Liu KH; Lee JW
Mol Metab; 2022 Apr; 58():101451. PubMed ID: 35123128
[TBL] [Abstract][Full Text] [Related]
38. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.
Dattaroy D; Pourhoseini S; Das S; Alhasson F; Seth RK; Nagarkatti M; Michelotti GA; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G298-312. PubMed ID: 25501551
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
[TBL] [Abstract][Full Text] [Related]
40. Tetraspanin TM4SF5 in hepatocytes negatively modulates SLC27A transporters during acute fatty acid supply.
Park D; Kim E; Lee H; Shin EA; Lee H; Lee JW
Arch Biochem Biophys; 2021 Oct; 710():109004. PubMed ID: 34364885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]